Valuation Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2025-12-04 am EST			5-day change	1st Jan Change
305.80 ^DKK	+0.66%		-2.67%	-51.01%

01:10pm	Novo Nordisk Presents New Topline Results from Their Evoke and Evoke+ Phase 3 Trials of Semaglutide	CI
09:39am	Indian Court Allows Dr. Reddy's to Produce Generic Versions of Novo Nordisk's Blockbuster Drugs -- 2nd Update	DJ

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	986,612	1,674,992	2,118,803	3,112,331	2,772,285	1,358,816	-	-
Change	-	69.77%	26.5%	46.89%	-10.93%	-50.99%	-	-
Enterprise Value (EV) ¹	984,211	1,684,152	2,121,013	3,109,107	2,848,764	1,460,050	1,455,837	1,438,482
Change	-	71.12%	25.94%	46.59%	-8.37%	-48.75%	-0.29%	-1.19%
P/E ratio	23.7x	35.4x	38.4x	37.5x	27.6x	13.3x	13.2x	12.2x
PBR	15.8x	24x	25.6x	29.4x	19.3x	7.24x	5.96x	5.11x
PEG	-	2.3x	2.2x	0.7x	1.3x	6.76x	26.04x	1.51x
Capitalization / Revenue	7.77x	11.9x	12x	13.4x	9.55x	4.42x	4.42x	4.11x
EV / Revenue	7.75x	12x	12x	13.4x	9.81x	4.74x	4.74x	4.35x
EV / EBITDA	16.4x	26x	25.8x	27.8x	19.3x	9.83x	9.78x	8.91x
EV / EBIT	18.2x	28.7x	28.4x	30.3x	22.2x	11.4x	11.2x	10.2x
EV / FCF	34.5x	57.4x	37x	45.5x	38.6x	29x	21.2x	16.4x
FCF Yield	2.9%	1.74%	2.7%	2.2%	2.59%	3.44%	4.72%	6.11%
Dividend per Share ²	4.55	5.2	6.2	9.4	11.4	11.64	11.55	12.39
Rate of return	2.13%	1.41%	1.32%	1.35%	1.83%	3.81%	3.78%	4.05%
EPS ²	9.005	10.37	12.22	18.62	22.63	23.08	23.19	25.06
Distribution rate	50.5%	50.1%	50.7%	50.5%	50.4%	50.4%	49.8%	49.4%
Net sales ¹	126,946	140,800	176,954	232,261	290,403	307,742	307,459	330,653
EBITDA ¹	59,879	64,669	82,171	111,987	147,446	148,604	148,800	161,530
EBIT ¹	54,126	58,644	74,809	102,574	128,339	128,557	129,591	140,372
Net income ¹	42,138	47,757	55,525	83,683	100,988	102,789	101,318	109,364
Net Debt ¹	-2,401	9,160	2,210	-3,224	76,479	101,234	97,021	79,666
Reference price ²	213.32	367.50	469.00	698.10	624.20	305.80	305.80	305.80
Nbr of stocks (in thousands)	4,624,923	4,557,801	4,517,704	4,458,288	4,441,340	4,443,479	-	-
Announcement Date	2/3/21	2/2/22	2/1/23	1/31/24	2/5/25	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
NOVO NORDISK A/S	13.16x	4.71x	9.78x	3.83%	211B
ELI LILLY AND COMPANY	45.19x	14.94x	33.19x	0.57%	925B
JOHNSON & JOHNSON	19.6x	5.5x	15.21x	2.52%	495B
ABBVIE INC.	53.78x	7.6x	18x	2.83%	407B
ROCHE HOLDING AG	18.2x	4.58x	11.46x	3.15%	335B
ASTRAZENECA PLC	27.53x	5.21x	15.44x	1.77%	283B
NOVARTIS AG	18.52x	5.01x	11.77x	3.05%	257B
MERCK & CO., INC.	13.22x	4.31x	9.21x	3.16%	254B
AMGEN INC.	25.28x	6.35x	10.9x	2.77%	186B
GILEAD SCIENCES, INC.	18.24x	5.74x	10.5x	2.65%	155B
Average	25.27x	6.39x	14.55x	2.63%	350.9B
Weighted average by Cap.	30.13x	8.01x	18.49x	2.22%